These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22920717)

  • 41. Heart rate achieved or beta-blocker dose in patients with chronic heart failure: which is the better target?
    Cullington D; Goode KM; Clark AL; Cleland JG
    Eur J Heart Fail; 2012 Jul; 14(7):737-47. PubMed ID: 22622001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
    de Boer RA; Doehner W; van der Horst IC; Anker SD; Babalis D; Roughton M; Coats AJ; Flather MD; van Veldhuisen DJ;
    Am J Cardiol; 2010 Jul; 106(1):78-86.e1. PubMed ID: 20609652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
    Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
    Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.
    Rosano GM; Vitale C; Volterrani M
    Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction.
    Chonchol M; Goldenberg I; Moss AJ; McNitt S; Cheung AK
    Am J Nephrol; 2007; 27(1):7-14. PubMed ID: 17204832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nemaline myopathy and heart failure: role of ivabradine; a case report.
    Sarullo FM; Vitale G; Di Franco A; Sarullo S; Salerno Y; Vassallo L; Baviera EP; Marazia S; Mandalà G; Lanza GA
    BMC Cardiovasc Disord; 2015 Jan; 15():5. PubMed ID: 25597856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: the DIAMOND study.
    Fosbøl EL; Seibaek M; Brendorp B; Moller DV; Thune JJ; Gislason GH; Torp-Pedersen C; Køber L;
    Int J Cardiol; 2010 Apr; 140(3):279-86. PubMed ID: 19095316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients.
    Feringa HH; Bax JJ; Boersma E; Kertai MD; Meij SH; Galal W; Schouten O; Thomson IR; Klootwijk P; van Sambeek MR; Klein J; Poldermans D
    Circulation; 2006 Jul; 114(1 Suppl):I344-9. PubMed ID: 16820598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-blocker use and outcomes among hospitalized heart failure patients.
    Butler J; Young JB; Abraham WT; Bourge RC; Adams KF; Clare R; O'Connor C;
    J Am Coll Cardiol; 2006 Jun; 47(12):2462-9. PubMed ID: 16781374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heart Rate As a Biomarker in Heart Failure: Role of Heart Rate Lowering Agents.
    Shaaya G; Al-Khazaali A; Arora R
    Am J Ther; 2017; 24(5):e532-e539. PubMed ID: 26360533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heart rate as a prognostic marker and therapeutic target in acute and chronic heart failure.
    Oliva F; Sormani P; Contri R; Campana C; Carubelli V; Cirò A; Morandi F; Di Tano G; Mortara A; Senni M; Metra M; Ammirati E
    Int J Cardiol; 2018 Feb; 253():97-104. PubMed ID: 29249470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Considerations on safety and treatment of patients with chronic heart failure at high altitude.
    Agostoni P
    High Alt Med Biol; 2013 Jun; 14(2):96-100. PubMed ID: 23795728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The benefits of ivabradine are independent of resting heart rate.
    Riccioni G
    Future Cardiol; 2013 May; 9(3):313-5. PubMed ID: 23668736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heart rate and heart failure. Not a simple relationship.
    Heusch G
    Circ J; 2011; 75(2):229-36. PubMed ID: 21041970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties.
    Dobre D; Borer JS; Fox K; Swedberg K; Adams KF; Cleland JG; Cohen-Solal A; Gheorghiade M; Gueyffier F; O'Connor CM; Fiuzat M; Patak A; Piña IL; Rosano G; Sabbah HN; Tavazzi L; Zannad F
    Eur J Heart Fail; 2014 Jan; 16(1):76-85. PubMed ID: 23928650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement?
    Bhatt AS; DeVore AD; DeWald TA; Swedberg K; Mentz RJ
    J Am Coll Cardiol; 2017 May; 69(20):2542-2550. PubMed ID: 28521892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Achieving Guideline-Directed Heart Rate ControlEarly Posthospitalization.
    Jungbauer CG; Maier LS; Emoto K; Zirille FM; Mirro MJ
    Am J Cardiol; 2019 Apr; 123(7):1096-1100. PubMed ID: 30683422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heart rate as a possible therapeutic guide for the prevention of cardiovascular disease.
    Inoue T; Iseki K; Ohya Y
    Hypertens Res; 2013 Oct; 36(10):838-44. PubMed ID: 23966053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heart rate awareness in patients with chronic stable heart failure. A multi-center observational study.
    Moran D; Buckley A; Daly K; Meaney B; Curtin R; O'Neill JO; Colwell N; Mahon N; Murphy N; O'Hanlon R; Daly C; Mc Adam B; Mc Donald K; Maher V
    Int J Cardiol; 2014 Dec; 177(2):380-4. PubMed ID: 25189497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-hospital Heart Rate Reduction With Beta Blockers and Ivabradine Early After Recovery in Patients With Acute Decompensated Heart Failure Reduces Short-Term Mortality and Rehospitalization.
    Faragli A; Tano GD; Carlini C; Nassiacos D; Gori M; Confortola G; Lo Muzio FP; Rapis K; Abawi D; Post H; Kelle S; Pieske B; Alogna A; Campana C
    Front Cardiovasc Med; 2021; 8():665202. PubMed ID: 34395550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.